Occupational lung disease pathophysiology

Jump to navigation Jump to search

Occupational lung disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Occupational lung disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Occupational lung disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Occupational lung disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Occupational lung disease pathophysiology

CDC on Occupational lung disease pathophysiology

Occupational lung disease pathophysiology in the news

Blogs on Occupational lung disease pathophysiology

Directions to Hospitals Treating Coalworker's pneumoconiosis

Risk calculators and risk factors for Occupational lung disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Occupational lung diseases include the pneumoconioses (interstitial lung diseases), hypersensitivity pneumonitis, bronchiolitis, byssinosis, and occupational asthma. Pneumoconiosis is an interstitial lung disease caused by the accumulation of different dust particles in the alveolar space. As the particles accumulate, the body's elimination mechanisms begin to fail, resulting in activation of chemotactic factors that exacerbate the inflammatory response, and subsequently lead to fibrosis. Hypersensitivity pneumonitis or extrinsic allergic alveolitis and its subcategories of, bronchiolitis, byssinosis, and occupational asthma are all part of the respiratory systems’ over reactivity towards inhalants.

Pathophysiology

Pathogenesis of pneumoconioses

  • The most common particles that cause pneumoconiosis are:
    • Asbestos
    • Silica (quartz, cristobalite, coesite, or tridymite silica polymorphs)
      • Structural differences between the polymorphs of silica, are important because of the different degrees of biological reactivity they present, making some of them more toxic than others. The biological reactivity makes quartz more toxic, followed by tridymite, cristobalite, coesite, and finally stishovite.
    • Coal
    • Other dust particles may also lead to pneumoconiosis, such as hydrated magnesium silicate, hydrous aluminum silicate, bauxite, cobalt, beryllium, and iron.
  • When particles reach the distal lung, the mucocilliary and lymphatic system take care of their elimination.
  • Dust fibers must be less than 3 μm in diameter in order to penetrate the distal lung.
  • Fibers greater than 5 μm are phagocytosed incompletely and retained in tissues.
  • When particles increase in number, macrophages are activated to engulf those particles.
  • Reticulin is then secreted by fibroblasts to entrap macrophages, as an attempt to control the excess of dust particles.
  • The physiology of macrophage activation is subject to several theories:
    • The macrophages are mainly derived from peripheral blood monocytes and, from local replication.
    • The recruitment of monocytes from peripheral blood occurs in response to several chemotactic factors suggest that one of the most potent chemotactic factors for peripheral blood monocytes is monocyte chemoattractant protein - 1 (MCP - 1), suggesting its role in chronic macrophage inflammation.
    • TNFα activates MCP - 1 expression. MCP - 1 is a 76 amino acid peptide that activates monocytes, also increases its cytostatic activity, and the expression of monocyte adhesion molecules such as CD11c/CD18 and CD11b/CD18.
  • As exposure continues, the elimination system begins to fail, leading to release of reactive oxygen species. These in turn exacerbate the inflammatory response, with the release of more cytokines, such as TNF and interleukins, which subsequently lead to fibrogenesis.
  • In asbestosis, the macrophages cannot eliminate the fibers, and cause needle-like formations containing iron to coalesce, these bodies are known as asteroid bodies.
  • In coal worker’s pneumoconiosis, coal dust trapped within the coalesced macrophages give a coal macule seen on x-ray.
  • The determinants for the rate of disease progression are the accumulative dose; that is based on duration and intensity of exposure, the fiber type and individual susceptibility.
  • The underlying pathogenic mechanisms that lead to pulmonary fibrosis in pneumoconiosis suggest a potential protective effect of TGF- β on the development of pulmonary fibrosis.
  • The alveolar macrophages in coal miners with massive fibrosis, secretes two main profibrotic factors; platelet-derived growth factor (PDGF) and insulin-like growth factor 1 (IGF - 1), whereas, the patients with simple pneumoconiosis secretes transforming growth factor - β (TGF - β). This reinforces that TGF- β has a possible protective effect against the development of pulmonary fibrosis.

Pathogenesis of hypersensitivity pneumonitis

Biological Reactivity of Different Dust Particles

  • Each dust particle has a different degree of biological reactivity.[3][4]
  • This variability is due to properties in the surface of the particles.
  • In the case of silica, there are two theories explaining their biological reactivity:

Shown below is a table summarizing the dust exposure associated with pneumoconiosis:

Disease Dust
Coal workers’ pneumoconiosis Coal dust
Silicosis Silica
Asbestosis Asbestos
Talcosis Hydrated magnesium silicate
Kaolin - induced pneumoconiosis Hydrous aluminum silicate
Mixed dust pneumoconiosis Coal dust, smoke from fires, and silicates
Aluminum - induced pneumoconiosis Bauxite (Al2O3)
Berylliosis Beryllium
Silicosiderosis Silica and iron
Hard - metal disease (giant cell pneumonitis) Cobalt

Associated Conditions

Conditions associated with occupational lung disease include:[1]

Caplan syndrome

  • In this syndrome, the joint manifestations of rheumatoid arthritis present with bilateral, peripheral lung nodules.
  • These nodules are unique from other pneumoconiotic nodules in that they develop rapidly over a period of weeks and may form cavities or become calcified.

Gross Pathology

  • On gross pathology, dilated airways, destruction and distortion of lung tissue, and discoloration of lung tissue are characteristic findings of occupational lung disease.[7]
Source:wikimediacommons, shows coal worker's pneumoconiosis complicated by progressive massive fibrosis by Yale Rosen from USA - Coal worker's pneumoconiosis - AnthracosilicosisUploaded by CFCF, CC BY-SA 2.0, https://commons.wikimedia.org/w/index.php?curid=31127927

Microscopic Pathology

  • On microscopic histopathological analysis, calcification, central necrosis, dense collagen, and sometimes malignant cells are characteristic findings of occupational lung disease.[8]

References

  1. 1.0 1.1 1.2 Castranova V, Vallyathan V (2000). "Silicosis and coal workers' pneumoconiosis". Environ Health Perspect. 108 Suppl 4: 675–84. PMC 1637684. PMID 10931786.
  2. name="pmid9072984">Boitelle A, Gosset P, Copin MC, Vanhee D, Marquette CH, Wallaert B; et al. (1997). "MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis". Eur Respir J. 10 (3): 557–62. PMID 9072984.
  3. 3.0 3.1 Vanhée D, Gosset P, Boitelle A, Wallaert B, Tonnel AB (1995). "Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis". Eur Respir J. 8 (5): 834–42. PMID 7656959.
  4. 4.0 4.1 McLoud TC (1991). "Occupational lung disease". Radiol. Clin. North Am. 29 (5): 931–41. PMID 1871262.
  5. name="pmid9072984">Boitelle A, Gosset P, Copin MC, Vanhee D, Marquette CH, Wallaert B; et al. (1997). "MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis". Eur Respir J. 10 (3): 557–62. PMID 9072984.
  6. name="pmid9072984">Boitelle A, Gosset P, Copin MC, Vanhee D, Marquette CH, Wallaert B; et al. (1997). "MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis". Eur Respir J. 10 (3): 557–62. PMID 9072984.
  7. name="pmid9072984">Boitelle A, Gosset P, Copin MC, Vanhee D, Marquette CH, Wallaert B; et al. (1997). "MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis". Eur Respir J. 10 (3): 557–62. PMID 9072984.
  8. name="pmid9072984">Boitelle A, Gosset P, Copin MC, Vanhee D, Marquette CH, Wallaert B; et al. (1997). "MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis". Eur Respir J. 10 (3): 557–62. PMID 9072984.